Last edition
News about "Elevar Therapeutics"
US FDA Approves Lirafugratinib for Cholangiocarcinoma
US FDA has approved lirafugratinib for previously treated, unresectable, locally advanced or metastatic cholangiocarcinoma.
Elevar Therapeutics | 25/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members